Ani Pharmaceuticals (ANIP) Gross Margin Growth (5y) (2017 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Gross Margin Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 824.00 |
| Mar 31, 2026 | -275.00 |
| Dec 31, 2025 | 228.00 |
| Sep 30, 2025 | -302.00 |
| Jun 30, 2025 | 740.00 |
| Mar 31, 2025 | 675.00 |
| Dec 31, 2024 | -503.00 |
| Sep 30, 2024 | -1,330.00 |
| Jun 30, 2024 | -1,304.00 |
| Mar 31, 2024 | -793.00 |
| Dec 31, 2023 | -533.00 |
| Sep 30, 2023 | -571.00 |
| Jun 30, 2023 | -118.00 |
| Mar 31, 2023 | 921.00 |
| Dec 31, 2022 | 469.00 |
| Sep 30, 2022 | 452.00 |
| Jun 30, 2022 | -60.00 |
| Mar 31, 2022 | -842.00 |
| Dec 31, 2021 | -1,138.00 |
| Sep 30, 2021 | -363.00 |